Josh Atkinson is an Assistant Professor in the Department of Civil and Environmental Engineering and the Omenn-Darling Bioengineering Institute at Princeton University. His research focuses on using synthetic biology and protein engineering to control electron transport in microbes for environmental applications, such as bioelectronic sensors and bioremediation. The Atkinson Lab investigates microbial energy processing, biofilm-electronic interfaces, and sustainable biotechnologies. Affiliations: Princeton University, Omenn-Darling Bioengineering Institute Research Interests: Microbial electron transport, bioelectronic systems, environmental monitoring, sustainable catalysis His work bridges disciplines like electrochemistry, bioengineering, and environmental science to engineer living materials for real-world challenges. The lab recruits students across levels, emphasizing diversity and interdisciplinary collaboration. Recent projects include real-time contaminant sensors and light-controlled biofilm patterning. Articles highlight innovations in bioelectronics and microbial systems engineering. The lab’s future directions involve scaling-up bioelectronic devices and enhancing microbial community understanding.
Jonathan Conway is an Assistant Professor in the Department of Chemical and Biological Engineering at Princeton University and an associated faculty member of the High Meadows Environmental Institute (HMEI). He leads the Conway Lab, which focuses on engineering plant-microbe interactions for applications in bioagriculture, bioenergy, and biochemical industries. Education: B.S. Chemical Engineering, University of Notre Dame (2011) M.S. Chemical Engineering, North Carolina State University (2013) Ph.D. Chemical Engineering, North Carolina State University (2017) Postdoctoral Fellow, University of North Carolina Chapel Hill & Howard Hughes Medical Institute (2017-2021) Research Interests: The Conway Lab develops genetic engineering approaches for non-model bacteria at plant-microbe interfaces. Key research areas include: chemical signaling between plants and microbes, microbiome impacts on plant immunity, environmental stress responses in agricultural systems, and enzymatic degradation of lignocellulosic biomass using thermophilic bacteria. The lab employs bacterial genetics, systems biology, and biomolecular engineering to create technologies for sustainable bioindustries. Publication Trends: Recent work demonstrates strong emphasis on molecular mechanisms of plant-microbe communication (2020-2024), enzyme characterization in biomass degradation (2024-2025), and development of synthetic microbial communities for climate resilience (2024). Earlier research focused on extremophile enzymology and metabolic engineering (2012-2019). Student Advising: Currently mentors 4 graduate students and 8 undergraduates. Alumni include 9 former advisees who graduated between 2022-2024. The lab actively recruits students through Princeton's Chemical Engineering graduate program and undergraduate research initiatives. Laboratory: The Conway Lab develops microfluidic systems for root microbiome studies and genetic tools for engineering plant-associated bacteria. Current projects include designing thermophilic microbial consortia for consolidated bioprocessing and characterizing bacterial immune evasion strategies.
Prof. Abbas Samani is a Professor at the Department of Electrical and Computer Engineering and holds a joint appointment in the Department of Medical Biophysics at Western University . He is a core faculty member of the Biomedical Engineering Graduate Program and an Associate Scientist at Imaging Research Laboratories of Robarts Research Institute . His academic journey includes a Ph.D. from the University of Waterloo, an M.Sc. from the University of Tehran, and a B.Sc. from Amirkabir University of Technology. His research focuses on biological tissue computational modeling and its applications in medical imaging, intervention, and image analysis . He develops computer/image-assisted tools for minimally invasive disease diagnosis and therapy , targeting heart disease, cancer, and lung disease . Key projects include myocardium biomechanical modeling , handheld medical devices for breast cancer screening , and lung disease diagnostics via CT image segmentation . His recent publications emphasize ultrasound elastography , finite element modeling , and inverse problems in biomechanics , primarily in journals like IEEE Transactions on Computational Imaging and Translational Oncology . His work spans both computational modeling and medical device development . Selected Graduate Supervision : Ph.D. Candidates : Seyed Hassan Haddad, Elham Karami, Seyed Mohammad Hesabgar Graduated Ph.D. Students : Ali Sadeghi Naini, Seyed Reza Mousavi M.Sc. Students : Cristian Linte, Patrick Courtis, Joseph O'Hagan, Hatef Mehrabian, Hirad Karimi, Hosein Amooshahi, Seyed Mohammad Hesabgar, Nastaran Ghadarghadr, Shadi Shavakh, Ehsan Salamati, Ehsan Omidi Teaching Contributions : Graduate: BME9519B/CAMI9519B/ECE9202B/ECE9022B - Advanced Image Processing and Analysis , MBP9530A - Human Biomechanics and Biomedical Applications Undergraduate: ECE4438B - Advanced Image Processing and Analysis , ES1050 - Introductory Engineering Design and Innovation Studio , MBP3330F - Human Biomechanics and Biomedical Applications Research Affiliations : Robarts Research Institute - Associate Scientist at Imaging Research Laboratories Western University - Core Faculty, Biomedical Engineering Graduate Program
Marcos Cruz is Professor of Innovative Environments at The Bartlett School of Architecture, University College London (UCL), where he leads research in bio-integrated design. He runs Bio-ID with Dr. Brenda Parker, a multidisciplinary research platform investigating design driven by biotechnology, computation, materials, and fabrication. Previously, he served as Director of The Bartlett from 2010-2014 and founded the BiotA Lab (2014-2018). His academic career spans multiple institutions including University College London (where he ran MArch Unit 20 for 19 years), University of Westminster (2008-2010), UCLA (2010), and IAAC (2014-present). Professor Cruz holds a Licenciatura from ESAP Porto, a Masters with distinction from UCL, and a PhD from UCL (2007), sponsored by the Portuguese Foundation for Science and Technology. His doctoral research on 'Neoplasmatic Architecture' earned him the RIBA President's Research Award in 2008. He is a registered architect with both the Architects Registration Board (ARB) and the Portuguese Architecture Chamber. His primary research area is Bio-Integrated Design, which explores how biotechnology and computation can reshape our built environment in response to climate change. This work goes beyond using nature as inspiration; instead, it treats nature as the medium for a multi-layered design approach. His key research project, Poikilohydric Living Walls, investigates integrating growth systems directly on building facades using algae and mosses that can switch photosynthetic activity on and off without additional maintenance. Another significant research area is The Body in Architecture, which examines the relationship between human flesh and architectural flesh, proposing a 'thick embodied flesh' that creates truly inhabitable architectural interfaces. His recent publications demonstrate a strong progression toward integrating living systems directly into building materials and facades. The research spans from microbial to tectonic scales, with increasing focus on biomaterials, robotic fabrication, and sustainable design approaches that actively participate in urban ecosystems rather than merely responding to them. RIBA President's Research Award (2008) for 'Neoplasmatic Architecture' Multiple Best Unit awards at Bartlett Summer Show (awarded by Thom Mayne, Paul Finch, Richard Rogers, Claude Parent, and Ross Lovegrove) Work part of permanent collection at FRAC Orleans Exhibitions at Venice and São Paulo Biennales Professor Cruz has supervised numerous PhD students through UCL's Research-by-Design programme and currently directs the MArch/MSc in Bio-Integrated Design. His research has been supported by EPSRC and involves industrial partners including Laing O'Rourke, Pennine Stone Limited, and Amorim, with academic partners at UCL Biochemical Engineering, University of Coimbra, and IST Tomar. He co-founded MAM-ARCH London (formerly marcosandmarjan) in 2000, whose work has built buildings and pavilions, won international competitions including the Kunsthaus Graz, and been exhibited globally. His practice represents a significant bridge between architectural design and biological systems, positioning him at the forefront of bio-integrated architectural research.
Prof. Joachim Spatz is a Full Professor of Biophysical Chemistry at Heidelberg University and Director of the Max Planck Institute for Medical Research. His academic career includes roles as Director at MPI for Metals Research (2004–2015) and Founding Director of the Institute for Molecular Systems Engineering (IMSE). He holds a PhD from Ulm University and habilitation in Physics, with postdoctoral training at the Institut Curie, Paris. His research spans cellular biophysics, materials science, and synthetic biology, focusing on mechanotransduction, cell-material interactions, and engineered biological systems. Education: 1989–1994: Dipl. Phys. (Physics), Ulm University & Colorado State University 1994–1996: PhD (summa cum laude), Ulm University 2000: Habilitation in Physics, Ulm University Research Interests: Spatz’s work integrates biophysics, materials science, and engineering to study cellular mechanics, synthetic cells, and mechanosensing. Key projects include developing synthetic cell models using microfluidics and exploring how mechanical forces regulate cell behavior in health and disease. Awards: 2017 Gottfried Wilhelm Leibniz Prize 2012 ERC Advanced Grant (with Prof. B. Geiger) 2002 Alfried Krupp Research Award Labs & Collaborations: Leads the Cellular Biophysics Department at MPI for Medical Research and collaborates with institutions like the Weizmann Institute and Jackson Laboratory. Active in interdisciplinary initiatives such as the Max Planck School Matter to Life.
Ovijit Chaudhuri is an Associate Professor of Mechanical Engineering at Stanford University, with a courtesy appointment in Bioengineering. He leads research at the interface of mechanics and biology, focusing on how cellular and extracellular mechanical properties influence biological processes like cancer progression and tissue formation. His work employs advanced tools such as atomic force microscopy and 3D cell culture systems. Education: Ph.D., University of California, Berkeley/San Francisco (Bioengineering, 2009) B.S., University of California, Berkeley (Engineering Physics, 2003) Postdoctoral Fellow, Harvard University (Biomaterials, 2013) Research Interests: His lab explores molecular mechanisms behind cellular mechanics, extracellular matrix dynamics, and how mechanical cues regulate cell behavior. Key areas include cancer metastasis, mechanotransduction, and engineered biomaterials for 3D cell culture. Publications Trends: Recent work emphasizes viscoelastic hydrogels, matrix mechanics in cancer progression, and mechanistic insights into cell migration. Over 50 publications since 2015 highlight interdisciplinary approaches in biomaterials and mechanobiology. Awards: Not explicitly listed in provided materials. Advising & Labs: No specific advisee names listed, but his lab focuses on collaborative projects in mechano-biology. Active in developing biomaterial systems for drug discovery and tissue engineering applications. Labs/Teams: Leads the Chaudhuri Lab at Stanford, which integrates engineering principles with biological systems to address complex disease mechanisms and therapeutic strategies.
Mohammad Peydayesh is a Lecturer and Senior Researcher at the Department of Health Sciences and Technology , ETH Zürich. He works in the Food and Soft Material Laboratory , focusing on sustainable materials derived from food waste and agri-food byproducts. PhD in Chemical Engineering (2018, Iran University of Science and Technology) Postdoctoral Fellow at ETH Zürich under Prof. Dr. Mezzenga Senior Assistant at ETH Zürich since 2021 His research spans soft matter , self-assembly phenomena , and amyloid fibril applications in: Environmental engineering (water purification, heavy metal removal) CO2 conversion and storage Smart packaging and bioplastics development Biorefinery concepts and circular economy Nanomaterials for waste valorization Recent publications highlight trends in amyloid-based hybrid materials for: Metal recovery from e-waste and contaminated water CO2 capture and conversion Bioplastic production from agricultural waste Antiviral and detoxification applications Water desalination and purification Photonic and catalytic materials He contributes to the Laboratory of Food & Soft Materials , advancing sustainable solutions through interdisciplinary material science.
Yevgeny Brudno, PhD, is an Associate Professor at the Eshelman School of Pharmacy (UNC-Chapel Hill) with a joint appointment in Biomedical Engineering (UNC and NC State University). He is a member of the UNC Lineberger Comprehensive Cancer Center and leads the Brudno Lab, which specializes in drug delivery and biomaterials for cancer immunotherapy, particularly CAR T cell therapy. Research Focus: Development of implantable biotechnologies for in vivo CAR-T cell production, biomaterials for therapeutic delivery, and click chemistry-based drug targeting. Education: PhD (unspecified institution). The lab’s research bridges chemical and biomaterials science with clinical needs, emphasizing on-demand drug release , solid tumor targeting , and autoimmune disease treatments . Recent work includes bioinstructive scaffolds and tissue-reactive drug depots , leveraging click chemistry and nanomedicine . His scientific contributions are highlighted by 15 publications (2009–2025) in fields like biotechnology, cancer immunotherapy, and epigenetics. Notable awards include the NCI MERIT Award , University Faculty Scholar (NC State), and Outstanding Teacher Award (NC State). Advising: Mentored 13 PhD and Master’s students, including Sharda Pandit (2023), Chris Moody (2021), and Emily Joe (2024). Lab announcements highlight student achievements like NSF and NIH fellowships. The Brudno Lab collaborates with UNC Lineberger and NC State, focusing on streamlining therapy production , enhancing efficacy in solid tumors , and autoimmune disease applications , supported by grants from NCI and CMI.
Jennica Zaro, PhD, serves as Associate Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California (USC) School of Pharmacy and Assistant Dean for Assessment in the Office of Graduate Education and Postdoctoral Studies. Previously, she held academic leadership roles at West Coast University School of Pharmacy and directed the Translational Research and Histology laboratories at USC Mann. Education: PhD in Pharmaceutical Sciences, University of Southern California BS, Stockton University Her pioneering research focuses on engineering recombinant fusion proteins for targeted drug delivery, particularly developing liver-specific insulin therapies for diabetes and pH-sensitive nanoconstructs for tumor targeting. This interdisciplinary work bridges protein engineering, nanomedicine, and translational pharmacology to create site-specific therapeutic systems with enhanced efficacy and reduced side effects. Analysis of her recent publications reveals a cohesive research trajectory centered on protein-drug conjugates, with significant contributions in pH-responsive delivery systems (2017-2018) and liver-targeted insulin analogs (2016-2018). Her work consistently appears in high-impact journals like Journal of Controlled Release and Biomaterials , demonstrating expertise in translating molecular designs into therapeutic applications. Scientific Awards: Most Innovative Award (2017, West Coast University) Advisor of the Year Award (2017, West Coast University, School of Pharmacy) Dr. Zaro has secured substantial research funding as Principal Investigator for NIH National Cancer Institute projects (2013-2016) and USC Ming Hsieh Institute grants (2014-2015), plus consultancy roles with Juvenile Diabetes Research Foundation (2016-2018). She actively shapes national research policy through service on NIH and UK Medical Research Council review panels and the American Foundation for Pharmaceutical Education Board of Grants. Her laboratory expertise includes the Translational Research and Histology core facilities at USC Mann, and she maintains active roles in professional organizations including the Controlled Release Society, American Association of Pharmaceutical Scientists, and American Association of Colleges of Pharmacy.
Li Tang is an Associate Professor with tenure at École polytechnique fédérale de Lausanne (EPFL), affiliated with the Institute of Bioengineering (IBI) and the Institute of Materials Science and Engineering (IMX) within the School of Engineering (STI). She leads the Laboratory of Biomaterials for Immunoengineering, focusing on developing innovative strategies at the intersection of immunology, materials science, and cancer therapy. Her work bridges fundamental research and clinical translation, with multiple ongoing clinical trials based on CAR-T cell therapies developed in her lab. B.S. in Chemistry, Peking University (2003–2007) Ph.D. in Materials Science and Engineering, University of Illinois at Urbana-Champaign (2007–2012) Postdoctoral Fellow, MIT (2013–2016) Her research lies at the forefront of immunoengineering, integrating chemical, metabolic, and mechanical approaches to modulate immune responses. Key areas include cancer immunotherapy, immune metabolism, mechano-immunology, and biomaterials. She investigates how physical and biochemical cues can reprogram T cells, overcome exhaustion, and enhance tumor targeting. Her work emphasizes multidimensional immunity-disease interactions, aiming to develop safer and more effective therapies for cancer and autoimmune diseases. The recent publications highlight a strong trend in engineering immune cells (especially CAR-T) for enhanced durability and function, using advanced biomaterials and metabolic reprogramming. There is a clear focus on overcoming challenges in solid tumors, modulating the tumor microenvironment, and translating findings into clinical applications. The use of nanoparticle delivery, single-cell analysis, and biomechanical cues are recurring themes across her work. Notable scientific awards include: Friedrich Miescher Award (2025) ERC Starting Grant (2018) MIT TR35 Innovators Under 35 (China Region, 2020) Nano Research Young Innovator Award (2018) Biomaterials Science Emerging Investigator (2019) Materials Horizons Emerging Investigator (2020) Li Tang actively mentors PhD students across multiple doctoral programs (EDBB, EDMS, EDMX) and has advised numerous graduates who have gone on to prestigious postdoctoral and faculty positions. She is involved in significant research grants, including an Innosuisse project with Novochizol SA, and her lab is supported by competitive funding. She teaches core courses such as Immunoengineering and Next-Generation Biomaterials, shaping the next generation of scientists. Her lab fosters interdisciplinary collaboration and innovation, with active projects in chemical, metabolic, and mechanical immunoengineering, as well as CAR-T cell development. She is the Principal Investigator of the Tang Lab, which includes postdoctoral fellows, PhD students, and technical staff. The lab is actively recruiting and has a strong publication and clinical translation record. Tang Lab is also involved in multiple MA/BA training projects and promotes student engagement in cutting-edge research. The lab’s discoveries are being translated into clinical trials, reflecting a strong commitment to translational science.
Robert O. Ritchie is the H. T. & Jessie Chua Distinguished Professor of Engineering at the University of California, Berkeley, where he holds dual appointments as Professor of Materials Science & Engineering and Professor of Mechanical Engineering. He is also a Faculty Senior Scientist at Lawrence Berkeley National Laboratory. His distinguished career spans over four decades with significant contributions to the field of materials science and engineering. Professor Ritchie received his B.A. in Physics & Metallurgy (1969), M.A. in Materials Science (1973), Ph.D. in Materials Science (1973), and Sc.D. in Materials Science (1990), all from Cambridge University, UK. His research focuses on the mechanical behavior of advanced materials, with particular emphasis on fracture mechanics, fatigue properties, and damage tolerance. Professor Ritchie's work spans multiple domains including metallic glasses, high-entropy alloys, biomaterials, and nature-inspired structural materials. His laboratory employs cutting-edge techniques such as in situ high-temperature computed tomography to study failure mechanisms in ceramic-matrix composites and nuclear graphite. His research has significant implications for aerospace, biomedical, and energy applications. Analysis of Professor Ritchie's recent publications reveals a strong focus on advanced structural materials, particularly metallic glasses and high-entropy alloys. His work combines experimental approaches with computational modeling to understand deformation mechanisms at multiple length scales. There is a clear trend toward bioinspired materials design, with several papers examining natural structures like fish scales, horn sheaths, and bone to develop new engineering materials with exceptional mechanical properties. Member, National Academy of Sciences (2025) Foreign Fellow, Academy of Athens, Greece (2024) Robert Henry Thurston Award (ASME) (2022) ASM Gold Medal (ASM Intl.) (2021) William D. Nix Medal, inaugural winner (TMS) (2020) Fellow (Foreign Member) of the Royal Society (FRS), London, UK (2017) Morris Cohen Award (TMS) (2017) Acta Materialia Gold Medal (2014) David Turnbull Award (MRS) (2013) A. Cemel Eringen Medal (Society of Engineering Science) (2010) Professor Ritchie has advised numerous graduate students and postdoctoral researchers throughout his career. His research has been supported by various funding agencies including the Department of Energy, National Science Foundation, and industry partners such as Rolls-Royce. He has served on numerous advisory boards including the Rolls-Royce Materials & Structures Advisory Board (2011-2019) and the Scientific Advisory Board of the Advanced Light Source at LBNL (2013 to date). Professor Ritchie leads the Ritchie Group at UC Berkeley, which maintains strong collaborations with Lawrence Berkeley National Laboratory. The laboratory employs state-of-the-art techniques including electron microscopy, x-ray tomography, and mechanical testing across multiple length and time scales. His team has developed innovative in situ characterization methods that have significantly advanced the understanding of material failure mechanisms under extreme conditions.
J. Edward Colgate is the Walter P. Murphy Professor of Mechanical Engineering and Director of the Human Augmentation via Dexterity (HAND) Engineering Research Center at Northwestern University's McCormick School of Engineering. He also holds the title of Breed Senior Professor of Design. His academic career includes leadership roles as founding co-Director of the Segal Design Institute and director of the Master of Science in Engineering Design and Innovation program. Colgate earned his Ph.D. (1988), S.M. (1986), and S.B. in Physics (1983) from the Massachusetts Institute of Technology. Colgate's research focuses on physical human-robot interaction with specialization in surface haptic interactive design and electroadhesion technology development. His work spans three interconnected domains: haptic interfaces (including wearable haptic arrays and Touchbot systems), robot dexterity through Shape-Based Remote Manipulation (SBRM) for overcoming communication delays, and high-speed electroadhesive actuators. The Northwestern Haptics Lab under his direction aims to create realistic virtual environments by merging these research vectors. His publications demonstrate consistent focus on tactile perception mechanisms, electroadhesion applications, and haptic rendering algorithms. Recent work explores texture playback fidelity, wearable electroadhesive arrays, robotic manipulation, and human-swarm control systems, reflecting interdisciplinary integration of mechanical engineering, materials science, and neuroscience principles. Awards: Elected to National Academy of Engineering (2021) for contributions to haptics, human-robot systems, and design education Inducted into National Academy of Inventors (2015) Educational initiatives include developing Northwestern's Design Thinking and Communication curriculum, establishing the Certificate in Engineering Design, and creating the Master of Science in Engineering Design and Innovation. He teaches ME 390: Introduction to System Dynamics using a flipped classroom model. Colgate directs the Northwestern Haptics Lab within the Center for Robotics and Biosystems, focusing on fundamental haptics research with applications in virtual reality, prosthetics, and human-assistive devices. The lab maintains active industry partnerships for technology transfer of haptic innovations.
Laurent Tapie is a Senior Lecturer at Paris Descartes University with a focus on Biomedical Engineering, Mechanical Engineering, and CAD/CAM . As Deputy Director of the URB2i research unit and manager of the PlatiNum platform , he coordinates the 3d4care.org consortium . His academic background includes a Doctorate in Mechanical Engineering from École Normale Supérieure de Cachan and authorization to direct research (HDR) from Université Paris 13. Research Interests: Mechanical Engineering, Biomedical Engineering, Medical Devices, CAD/CAM, Shaping of Biomaterials Theses Supervised: 3D evaluation of dento-prosthetic joints, impact of CAD/CAM on dental prosthesis integrity, and metrological evaluations of prostheses. Publications: His work spans dental CAD/CAM systems, surface integrity of prostheses, additive manufacturing, and 3D printing applications during the COVID-19 pandemic . Recent articles focus on data dispersion in CAD/CAM chains, tool-material influence on roughness, and numerical workflow standardization . Scientific Award: Prix du comité scientifique de la session recherche (2019). Projects: Currently leads initiatives like ProGéoMéca (Labex LaSIPS), Bio-Dents (CNRS Biomimicry), and additive process development for multi-material dental aligners .
Hedvig Kjellström is a Professor at the Division of Robotics, Perception and Learning within the School of Electrical Engineering and Computer Science at KTH Royal Institute of Technology. She holds significant affiliations with the Swedish e-Science Research Centre and the Max Planck Institute for Intelligent Systems in Germany. Her work spans multiple interdisciplinary domains and she serves as Editor-in-Chief for CVIU and was Program Chair for CVPR 2025. Her research centers on Computer Vision as a sub-field of AI, with three interconnected themes: Computational Aesthetics (exploring aesthetic aspects of human communicative behavior), Communicative Behavior (developing models of how humans and animals perceive and produce non-verbal communication), and Embodied Artificial Intelligence (creating methodologies for robots and autonomous agents to perceive the world through sensors, primarily vision). Her work has significant applications in medical diagnostics, animal welfare, human-robot interaction, and creative arts. Analysis of her recent publications reveals a strong trend toward multimodal AI systems that integrate vision, language, and action understanding. Her research increasingly focuses on animal-centered applications, particularly equine pain detection and behavior analysis, while maintaining strong foundations in human communication modeling, gesture recognition, and 3D reconstruction techniques. The interdisciplinary nature of her work bridges computer science with veterinary medicine, neuroscience, and performing arts. Hedvig Kjellström actively supervises numerous PhD and Master's students across various projects and maintains extensive collaborations with institutions including Karolinska Institutet, Swedish University of Agricultural Sciences, and international partners. Her research is supported by major funding bodies including WASP, VR, and SeRC. She leads or participates in several notable projects including OrchestrAI (communication between conductor and orchestra), ANITA (Animal Translator), MARTHA (3D horse motion analysis), and STING (synthesis and analysis with transducers and invertible neural generators). Her work with ACAI (Animal Centered Artificial Intelligence), which she co-founded and directs, demonstrates her commitment to applying AI for animal welfare.
Hsueh-Chia Chang is the Bayer Professor of Chemical Engineering in the Department of Chemical and Biomolecular Engineering at the University of Notre Dame's College of Engineering. He also holds a concurrent faculty position in the Department of Aerospace and Mechanical Engineering. As Principal Investigator of the Chang Lab, he leads cutting-edge research in microfluidic and nanofluidic technologies for biomedical applications. Prof. Chang received his B.S. in Chemical Engineering from Caltech in 1976, followed by M.S. and Ph.D. degrees in Chemical Engineering from Princeton University in 1977 and 1980, respectively. His academic journey has established him as a leader in the field of microfluidics and biosensing technologies. Chang's research focuses on developing low-cost liquid biopsy nanotechnologies for cancer screening and therapy management. His lab specializes in microfluidic and nanofluidic research coupled with electrokinetics, optics, plasmonics and acoustics for biosensing applications. Key research areas include Electrokinetics & Biosensing, Optics & Plasmonics, Nanoelectrokinetics, and Droplet Microfluidics. The Chang Lab has developed innovative platforms that can isolate and sort tumor cells, exosomes, microvesicles, lipoproteins, and stress granules from blood samples, then lyse these structures to release RNA/protein biomarkers for detection and quantification. His recent publications reveal a strong focus on extracellular vesicle diagnostics, cancer biomarker detection, and point-of-care diagnostic technologies. The research spans multiple disciplines including oncology, cardiology, and neurology, with applications for pancreatic, liver, breast, ovarian, and lung cancers as well as myocardial infarction diagnosis. Fellow of American Institute of Medical and Biological Engineering (2025) Provost Research Achievement Award, Notre Dame (2024) Fellow of the National Academy of Inventors (2020) Lifetime Achievement Award, American Electrophoresis Society (2019) Fellow of the American Physical Society (1997) Presidential Young Investigator Award, NSF (1985) Prof. Chang has advised over 50 PhD students and postdocs who have gone on to prominent positions in academia and industry. His lab has secured significant funding and has commercialized several technologies through startups like Aopia Biosciences, which launched NanoEx at ISEV 2024. The Chang Lab maintains active collaborations with medical researchers for validating their diagnostic platforms against various cancers and cardiac conditions.
